Skip to Main Content

Author Details

Matthieu Duchmann
Assistance Publique-Hopitaux de Paris, Universite de Paris
2015
23
9
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36630200Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.Blood Cancer Discov2023
36736290Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.Cell Stem Cell2023
34615986Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.Leukemia2022
35443031Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.Blood2022
35474100Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.Leukemia2022
35750691A multiparametric niche-like drug screening platform in acute myeloid leukemia.Blood Cancer J2022
36494771Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.BMC Bioinformatics2022
36307762Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.BMC Bioinformatics2022
36201165Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.Clin Cancer Res2022
36151081Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.Blood Cancer J2022
32581253Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy.Leukemia2021
33881523Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.Blood2021
34638371Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias.Cancers (Basel)2021
34423258Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers.Hemasphere2021
33043739Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.Leuk Lymphoma2021
32889375High effector-memory CD8<sup>+</sup> T-cell levels correlate with high PML risk in natalizumab-treated patients.Mult Scler Relat Disord2020
31020568Clinical update on hypomethylating agents.Int J Hematol2019
30894665Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia.Leukemia2019
29728305Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.EBioMedicine2018
28498370Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.Blood Cancer J2017
28140711Choosing a hypomethylating agent in MDS: does gender matter?Leuk Lymphoma2017
28455647CMML: Clinical and molecular aspects.Int J Hematol2017
26410692[Management of myelodysplastic syndromes].Bull Cancer2015
  • 1 - 23 of 23

Recommended Authors

Oregon Health and Science University
Career Start Year 2018
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2017
Number of shared co-authors 0
University of Miami, Sylvester Comprehensive Cancer Center
Career Start Year 2014
Number of shared co-authors 3
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 0
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 7
The Ohio State University
Career Start Year 2008
Number of shared co-authors 1
UT MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 7
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 1
University of Colorado Division of Hematology
Career Start Year 2004
Number of shared co-authors 1
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 0
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 1
Hannover Medical School
Career Start Year 2002
Number of shared co-authors 3
and Blood Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 1
Moores Cancer Center, university of california san diego
Career Start Year 2001
Number of shared co-authors 1
Hopp Children's Cancer Center (KiTZ)
Career Start Year 2000
Number of shared co-authors 11
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 1
University of Texas M.D. Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 6
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 4
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 0
The University of Chicago
Career Start Year 1994
Number of shared co-authors 5
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 6
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 4
Fred Hutchinson Cancer Research Centre
Career Start Year 1987
Number of shared co-authors 2
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 10
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1983
Number of shared co-authors 8

Collaborators

Universite Paris Cite, INSERM, CNRS
Co-authored papers 18
Assistance Publique des Hopitaux de Paris (AP-HP)
Co-authored papers 11
Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers 10
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 9
Saint-Louis Hospital
Co-authored papers 8
Universite Paris Diderot
Co-authored papers 7
Centre Hospitalier Universitaire Hopital Avicenne
Co-authored papers 6
INSERM U7, Universite Paris-Saclay
Co-authored papers 6
Avicenne Hospital
Co-authored papers 4
University of Paris
Co-authored papers 4
Universite Paris Cite, INSERM, CNRS
Co-authored papers 3
Universite de Paris, INSERM, CNRS
Co-authored papers 3
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Universite Paris Cite, Inserm, CNRS, Institut de Recherche Saint-Louis
Co-authored papers 2
CHU La Miletrie University Hospital Poitiers France.
Co-authored papers 2
Universite Nice Cote d'azur, CHU de Nice
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Universite Paris Cite, Institut de Recherche Saint-Louis
Co-authored papers 2
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Chaoyang University of Technology
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
University of Cambridge
Co-authored papers 1
INSERM U1170, Universite Paris Saclay
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Universite Paris-Saclay
Co-authored papers 1